To identify factors which influence MTMR7 expression, we analysed a second independent cohort of CRC patients with metabolic parameters known to activate RTK signaling: type 2 diabetes mellitus (T2DM) and loss of imprinting (LOI) of the IGF2 gene in the tumor. This evidence concerns the gene MTMR7 and diabetes mellitus.